Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
about
Molecular phenotypes of colorectal cancer and potential clinical applicationsEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionToward a Molecular Classification of Colorectal Cancer: The Role of MGMTDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyThe molecular background of mucinous carcinoma beyond MUC2BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsSerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancerKRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).Characterization of rare transforming KRAS mutations in sporadic colorectal cancer.Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Proceedings of the second international molecular pathological epidemiology (MPE) meetingPrediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patientsRelationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer.Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stagesDistinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational studySomatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma.Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study.Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.Reduced rate of copy number aberrations in mucinous colorectal carcinoma.Integration of molecular pathology, epidemiology and social science for global precision medicine.Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.Colorectal cancer carcinogenesis: a review of mechanismsHistone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancerReview Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationAspirin use and risk of colorectal cancer according to BRAF mutation statusPrognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour locationOncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
P2860
Q26785725-8359C9C7-5A90-4352-9208-C9151DCBDF10Q26852716-76B37A7F-D415-4672-912D-4B8216BE8F3CQ26862363-9D858758-A675-443C-B322-EBC63A23CD11Q27011884-A8537D8B-7C01-4444-A522-16F8DC3104F9Q28083904-C124B28B-6840-4C01-B14C-4C5E0F181DE3Q28543370-C7BEA2F2-39ED-4226-8C3E-6309D366422DQ30842687-CEED7DFA-115E-4A6D-8CB8-1C73CE0E1907Q33693309-25D80341-47E0-44F2-BF97-82AB0BF6B04FQ33727871-FCDF108D-1216-4C03-887E-05CB9F6F8BEBQ33732199-78453F96-3B92-4DDE-96CE-B35C5FDE2CECQ33768220-72943614-91AE-41FF-B1FB-91F765723B02Q33855053-3C5F23B8-187D-45A3-820B-3C7A500E2B43Q34016833-E5212CC4-7E23-449C-A17E-2770FA3B155BQ34475686-118276F6-35E6-481E-9C9F-E132D0C85B93Q34502713-B353831F-77FB-4158-821A-BA81022D797BQ34778710-B9EB1670-80C7-4677-B46D-67C68397DEDDQ35045790-5BC6B1AA-4475-4FAE-827C-614B0F6999FEQ35137250-DC0D1B85-611D-479E-A86A-B335B1E831D8Q35579056-1E758D11-D308-4A16-8A43-B7BC8A31DEEEQ35652713-407FE336-3059-46A4-909E-50CBE7B71F48Q35773077-6E22F328-852F-4CEF-8325-E46629AEDE87Q36050773-4FE9D810-32E7-43BC-BF31-FFDBD4B0D54DQ36108299-EECE4E78-606D-4D4A-8CB5-9FD6A2441E25Q36137083-4DEBEFA8-497B-4695-AFDD-568510137A21Q36201032-09E77BA9-518C-4F91-BFB1-F162D77E2603Q36245897-058CE8DE-D0BA-4FF3-A020-22F07CAD228AQ36405971-1F877627-9828-462A-B9D0-F1EFC747FFAAQ36413276-1453B10F-288E-43A2-9AEE-41D0642DB55DQ36463854-B92E1747-0DDC-4080-92B8-77F580A0931BQ36602836-6BA3A31F-960D-4B55-B983-1C7A93FA8716Q36849645-753C1267-436D-43CC-9DFE-ECADBBAAD99BQ36853881-17063225-CF5A-4E8A-BE44-25F0F7AF58B6Q36926941-4D2AB6E1-A08D-42D6-B573-39FC26D5EABCQ36968401-0DC288FB-A054-4CB5-B5F2-DD46FEA8C223Q37075412-1848872F-DDAA-4F9C-8B7D-410B1D50BA84Q37094281-34F567FE-D420-4D0E-A694-CD3F3C066402Q37111201-8F2882E1-6A6C-422B-A60A-D095DB4A93DEQ37241845-45631A40-CD9F-408C-AE00-0E8EBDA73E9BQ37360360-314739F9-3989-4A07-8EAC-0B9C8556049FQ37608405-FD33F379-1448-4C5A-8799-DA21C72A4D9F
P2860
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Colorectal carcinomas with KRA ...... logical and molecular features
@ast
Colorectal carcinomas with KRA ...... logical and molecular features
@en
Colorectal carcinomas with KRA ...... logical and molecular features
@nl
type
label
Colorectal carcinomas with KRA ...... logical and molecular features
@ast
Colorectal carcinomas with KRA ...... logical and molecular features
@en
Colorectal carcinomas with KRA ...... logical and molecular features
@nl
prefLabel
Colorectal carcinomas with KRA ...... logical and molecular features
@ast
Colorectal carcinomas with KRA ...... logical and molecular features
@en
Colorectal carcinomas with KRA ...... logical and molecular features
@nl
P2093
P2860
P50
P3181
P1433
P1476
Colorectal carcinomas with KRA ...... logical and molecular features
@en
P2093
Belinda Nagler
David Pakenas
Erika Pavluk
Jeremy R Jass
Joanne P Young
Mark Clendenning
Michael D Walsh
Rhiannon J Walters
Sally Pearson
Susan Parry
P2860
P2888
P304
P3181
P356
10.1038/MODPATHOL.2012.240
P407
P50
P577
2013-06-01T00:00:00Z
P5875
P6179
1035805591